Neurotoxin-induced lesions to central serotonergic, noradrenergic and dopaminergic systems modify caffeine-induced antinociception in the formalin test and locomotor stimulation in rats

Journal of Pharmacology and Experimental Therapeutics

Volumn 277, Issue 2, 1996, Pages 646-653

  Sawynok, Jana ^a   Reid, Allison ^a  

^a DALHOUSIE UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

5,7 DIHYDROXYTRYPTAMINE; CAFFEINE; DESIPRAMINE; NEUROTOXIN; OXIDOPAMINE; PHENTOLAMINE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DOPAMINERGIC SYSTEM; DRUG INHIBITION; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; INTRAPERITONEAL DRUG ADMINISTRATION; LOCOMOTION; LOCUS CERULEUS; MALE; NEUROTOXICITY; NONHUMAN; NORADRENERGIC SYSTEM; PRIORITY JOURNAL; RAT; SEROTONINERGIC SYSTEM;

5,7-DIHYDROXYTRYPTAMINE; ANALGESIA; ANIMALS; BRAIN; CAFFEINE; CENTRAL NERVOUS SYSTEM STIMULANTS; DOPAMINE; FORMALDEHYDE; MALE; MOTOR ACTIVITY; NOREPINEPHRINE; OXIDOPAMINE; RATS; RATS, SPRAGUE-DAWLEY; SEROTONIN;

EID: 0030423665     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (54)

1. ABBOTT, F. V. AND MELZACK, R.: Brainstem lesions dissociate neural mechanisms of morphine analgesia in different kinds of pain. Brain Res. 251: 149-155, 1982.
2. 3-like receptor supersensitivity and dopamineeceptor supersensitivity in the rat medial prefrontal cortex after the intraventricular administration of the neurotoxin 5,7-dihydroxytryptamine: A microiontophoretic study Neuroscience 60: 453-462, 1994.
3. BÄTTIG, K. AND WELZL, H.: Psychopharmacological profile of caffeine. In Caffeine, Coffee and Health, ed. by S. Garattini, pp. 213-253, Raven Press, New York, 1993.
4. BERKOWITZ, B. A. AND SPECTOR, S.: The effect of caffeine and theophylline on the disposition of brain serotonin in the rat. Eur. J. Pharmacol. 16: 322-325, 1971.
5. BERKOWITZ, B. A., TARVER, J. H. AND SPECTOR, S.: Release of norepinephrine in the central nervous system by theophylline and caffeine. Eur. J. Pharmacol. 10: 69-71, 1970.
6. BRADBURY, A. J., COSTALL, B., NAYLOR, R. J. AND ONAIVI, E. S.: 5-Hydroxytryptamine involvement in the locomotor activity suppressant effects of amphetamine in the mouse. Psychopharmacology (Berl ) 93: 457-465, 1987.
7. CHOI, O. H., SHAMIM, M. T., PADGETT, W. L. AND DALY, J. W.: Caffeine and theophylline analogues: Correlation of behavioral effects with activity as adenosine receptor antagonists and as phosphodiesterase inhibitors. Life Sci. 43: 387-398, 1988.
8. CRAIG, K. D.: Emotional aspects of pain. In: Textbook of Pain, ed. P. D. Wall and R. Melzack, pp. 261-274, Churchill Livingstone, New York, 1994.
9. DALY, J. W.: Mechanism of action of caffeine. In: Caffeine, Coffee and Health, ed. S. Garattini, pp. 97-150, Raven Press. New York, 1993.
10. ELAM, M., SVENSSON, T. H. AND THORÉN, P.: Locus coeruleus neurons and sympathetic nerves: Activation by cutaneous sensory afferents Brain Res. 366: 254-261, 1986.
11. ERINOFF, L., MACPHAIL, R. C., HELLER, A. AND SEIDEN, L. S.: Age-dependent effects of 6-hydroxydopamine on locomotor activity in the rat. Brain Res. 164: 195-205, 1979.
12. ERINOFF, L AND SNODGRASS, S. R.: Effects of adult or neonatal treatment with 6-hydroxydopamine or 5,7-dihydroxytryptamine on locomotor activity, monoamine levels and response to caffeine. Pharmacol. Biochem. Behav. 24: 1039-1045, 1986.
13. ESTLER, C.-J.: Effect of α- and β-adrenergic blocking agents and parachlorophenylalanine on morphine- and caffeine-stimulated locomotor activity of mice. Psychopharmacologia (Berl.) 28: 261-168, 1973.
14. FASMER, O. B., BERGE, O.-G. AND HOLE, K.: Changes in nociception after lesions of descending serotonergic pathways induced with 5,6-dihydroxytryptamine. Neuropharmacology 24: 729-734, 1985.
15. FERNSTROM, M. H., BAZIL, C. W. AND FERNSTROM, J. D : Caffeine injection raises brain tryptophan levels, but does not stimulate the rate of serotonin synthesis in rat brain. Life Sci. 35: 1241-1247, 1984.
16. FERNSTROM, J. D. AND FERNSTROM, M. H.: Effects of caffeine on monoamine neurotransmitters in the central and peripheral nervous system. In: Caffeine: Perspectives from Recent Research, ed. P. B. Dews, pp. 107-118, Springer, Heidelberg, 1984.
17. FERRÉ, S., FUXE, K., VON EULER, G., JOHANSSON, B. AND FREDHOLM, B. B.: Adenosine-dopamine interactions in the brain. Neuroscience 3: 501-512, 1992.
18. FINN, I. B. AND HOLTZMAN, S. G.: Pharmacological specificity of tolerance to caffeine-induced stimulation of locomotor activity. Psychopharmacology 93: 428-434, 1987.
19. FINN, I. B., IUVONE, P. M. AND HOLTZMAN, S. G.: Depletion of catecholamines in the brain of rats differentially affects stimulation of locomotor activity by caffeine, D-amphetamine and methylphenidate. Neuropharmacology 29: 625-631, 1990.
20. 2 dopamine receptor antagonists block caffeine-induced stimulation of locomotor activity in rats. Pharmacol. Biochem. Behav 47: 89-94, 1994a.
21. 2 receptor agonists but not to their synergistic interaction. Eur. J. Pharmacol. 262: 65-75, 1994b.
22. GEYER, M. A., PUERTO, A., MENKES, D. B., SEGAL, D. S. AND MANDELL, A. J.: Behavioral studies following lesions of the mesolimbic and meaostriatal serotonergic pathways. Brain Res. 106: 257-270, 1976.
23. GOLDBERG, M. R., CURATOLO, P. W., TUNG, C. S. AND ROBERTSON, D.: Caffeine down-regulates β adrenoreceptors in rat forebrain. Neurosci. Lett. 31: 47-52, 1982.
24. GRIFFITHS, R. R., EVANS, S. M., HEISHMAN, S. J., PRESTON, K. L., SANNERUD, C. A., WOLF, B. A. AND WOODSON, P. P.: Low-dose caffeine discrimination in humans. J. Pharmacol. Exp. Ther. 252: 970-978, 1990.
25. HADFIELD, M. G. AND MILIO, C.: Caffeine and regional brain monoamine utilization in mice. Life Sci. 45: 2637-2644, 1989.
26. HOLTZMAN, S. G.: Discriminative stimulus properties of caffeine in the rat: Noradrenergic mediation. J. Pharmacol. Exp. Ther. 239: 706-714, 1986.
27. HONG, M., MILNE, B., LOOMIS, C. W. AND JHAMANDAS, K.: In vivo catechol activity in the rat locus coeruleus following different noxious stimuli and naloxone. Can J. Physiol. Pharmacol. 70: 1082-1089, 1992.
28. HOWE, J. R. AND YAKSH, T. L.: Changes in sensitivity to intrathecal norepinephrine and serotonin after 6-hydroxydopamine (6-O. H. D.A), 5,6-dihydroxytryptamine (5,6-D. H. T.) or repeated monoamine administration. J. Pharmacol. Exp. Ther. 220: 311-321, 1982.
29. 1 adenosine receptor occupancy. Neuropsychopharmacology 6: 145-153, 1992.
30. KIRCH, D. G., TAYLOR, T. R., GERHARDT, G. A., BENOWITZ, N. L., STEPHEN, C. AND WYATT, R. J.: Effect of chronic caffeine administration on monoamine and monoamine metabolite concentrations in rat brain. Neuropharmacology 29: 599-602, 1990.
31. LE BARS, D.: Serotonin and pain, In Neuronal Serotonin, ed. by N. N. Osborne and M. Hamon, pp. 171-229, John Wiley & Sons Ltd, Chichester, 1988.
32. MILLER, F. P., COX, R. H., SNODGRASS, W. B. AND MAICKEL, R. P.: Comparative effects of para-chlorophenylalanine, parachloroamphetamine and parachloro-N-methylamphetamine on rat brain norepinephrine, serotonin and 5-hydroxyindole-3-acetic acid. Biochem. Pharmac. 19: 435-442, 1970.
33. NEHLIG, A., DAVAL, J.-L. AND DEBRY, G., CAFFEINE AND THE CENTRAL NERVOUS SYSTEM: mechanisms of action, biochemical, metabolic and psychostimulant effects. Brain Res. Rev. 17: 139-170, 1992.
34. OLPE, H.-R., JONES, R. S. G. AND STEINMANN, M W : The locus coeruleus: Actions of psychoactive drugs. Experientia 39: 242-249, 1983.
35. PAN, W. J., OSMANOVI[AA]C, S. S. AND SHEFNER, S. A.: Adenosine decreases action potential duration by modulation of A-current in rat locus coeruleus neurons. J. Neurosci. 14: 1114-1122, 1994.
36. POST, C., PERSSON, M. L., ARCHER, T., MINOR, B. G., DANYSZ, W. AND SUNDSTROM, E.: Increased antinociception by α-adrenoceptor drugs after spinal cord noradrenaline depletion. Eur. J. Pharmacol. 137: 107-116, 1987.
37. PROUDFIT, H. K.: Pharmacologic evidence for the modulation of nociception by noradrenergic neurons. In Progress in Brain Research, Vol. 77, ed. by H. L. Fields and J.-M. Besson, pp. 357-370, Elsevier Science Publishers B. V., Amsterdam, 1988.
38. RAY, S. K. AND PODDAR, M. K.: Role of central serotonin in caffeine-induced stimulation of locomotor activity in rat. Biogen. Amines 7: 153-164, 1990.
39. RYAN, S. M., WATKINS, L. R., MAYER, D. J. AND MAIER, S. F.: Spinal pain suppression mechanisms may differ for phasic and tonic pain. Brain Res. 334: 172-175, 1985.
40. SAWYNOK, J.: Adenosine and pain. In Adenosine and Adenine Nucleotides as Regulators of Cellular Function, ed. by J. W. Phillis, pp. 391-400, CRC Press, Boca Raton, FL, 1991.
41. SAWYNOK, J. AND REID, A.: Effect of 6-hydroxydopamine-induced lesions to ascending and descending noradrenergic pathways on morphine analgesia. Brain Res. 419: 156-165, 1987.
42. 3 receptor agonists following 5,7-dihydroxytryptamine. Eur. J. Pharmacol. 264: 249-257, 1994.
43. SAWYNOK, J., REID, A. R. AND DOAK, G. J.: Caffeine antinociception in the rat hot plate and formalin test and locomotor stimulation: Involvement of noradrenergic mechanisms. Pain 61: 203-213, 1995.
44. SAWYNOK, J. AND YAKSH, T. L.: Caffeine as an analgesic adjuvant: a review of pharmacology and mechanisms of action. Pharmacol. Rev. 45: 43-85, 1993.
45. SCHLOSBERG, A. J., FERNSTROM, J. D., KOPCZYNSKI, M. C., CUSAK, B. M. AND GILLIS, M. A.: Acute effects of caffeine injection on neutral amino acids and brain monoamine levels in rats. Life Sci. 29: 173-183, 1981.
46. SHEFNER, S. A. AND CHIU, T. H.: Adenosine inhibits locus coeruleus neurons: An intracellular study in a rat brain slice preparation Brain Res. 306: 364-368, 1986.
47. SHIEKHATTER, R. AND ASTON-JONES, G.: Sensory responsiveness of brain noradrenergic neurons is modulated by endogenous brain serotonin. Brain Res. 623: 72-76, 1993.
48. SNYDER, S. H., KATIMS, J. J., ANNAU, Z., BRUNS, R. F. AND DALY, J. W.: Adenosine receptors and behavioral actions of methylxanthines. Proc. Natl. Acad. Sci. U.S.A. 78: 3260-3264, 1981.
49. SWERDLOW, N. R., VACCARINO, F. J., AMALRIC, M. AND KOOB, G. F.: The neural substrates for the motor-activating properties of psychostimulants: A review of recent findings. Pharmacol. Biochem. Behav. 25: 233-248, 1986.
50. SYLVÉN, C.: Mechanisms of pain in angina pectoris - A critical review of the adenosine hypothesis. Cardiovasc. Drugs. Ther. 7: 745-759, 1993.
51. TJØLSEN, A., BERGE, O.-G. AND HOLE, K.: Lesions of bulbo-spinal serotonergic or noradrenergic pathways reduce nociception as measured by the formalin test. Acta Physiol. Scand. 142: 229-236, 1991.
52. TJØLSEN, A., BERGE, O.-G., HUNSKAAR, S., ROSLAND, J. H. AND HOLE, K.: The formalin test: an evaluation of the method. Pain 51: 5-17, 1992.
53. WALDECK, B.: Some effects of caffeine and aminophylline on the turnover of catecholamines in the brain. J. Pharm. Pharmacol. 23: 824-830, 1971.
54. WHITE, B. C., SIMPSON, C. C., ADAMS, J. E. AND HARKINS, D.: Monoamine synthesis and caffeine induced locomotor activity. Neuropharmacology 17: 511-513, 1978.